Registries for Evaluating Patient Outcomes

Registries for Evaluating Patient Outcomes PDF Author: Agency for Healthcare Research and Quality/AHRQ
Publisher: Government Printing Office
ISBN: 1587634333
Category : Medical
Languages : en
Pages : 385

Get Book Here

Book Description
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.

Registries for Evaluating Patient Outcomes

Registries for Evaluating Patient Outcomes PDF Author: Agency for Healthcare Research and Quality/AHRQ
Publisher: Government Printing Office
ISBN: 1587634333
Category : Medical
Languages : en
Pages : 385

Get Book Here

Book Description
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.

Appellate Mediation Program

Appellate Mediation Program PDF Author: United States. Court of Appeals (District of Columbia Circuit)
Publisher:
ISBN:
Category : Appellate procedure
Languages : en
Pages : 12

Get Book Here

Book Description


An Evaluation of Mediation and Early Neutral Evaluation Under the Civil Justice Reform Act

An Evaluation of Mediation and Early Neutral Evaluation Under the Civil Justice Reform Act PDF Author: James S. Kakalik
Publisher: RAND Corporation
ISBN: 9780833024756
Category : Arbitration and award
Languages : en
Pages : 0

Get Book Here

Book Description
This study found that, once litigation had begun, referral to ADR was not a panacea, nor was it detrimental.

ADR Report

ADR Report PDF Author:
Publisher:
ISBN:
Category : Dispute resolution (Law)
Languages : en
Pages : 570

Get Book Here

Book Description


Recommendations and Reports

Recommendations and Reports PDF Author: Administrative Conference of the United States
Publisher:
ISBN:
Category : Administrative agencies
Languages : en
Pages : 1032

Get Book Here

Book Description


Prevention Report

Prevention Report PDF Author:
Publisher:
ISBN:
Category : Health promotion
Languages : en
Pages : 182

Get Book Here

Book Description


Guideline for Postmarketing Reporting of Adverse Drug Reactions, [docket No. 85D-0249]

Guideline for Postmarketing Reporting of Adverse Drug Reactions, [docket No. 85D-0249] PDF Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 52

Get Book Here

Book Description


Clinically Oriented Pharmacology

Clinically Oriented Pharmacology PDF Author:
Publisher: Quick Review of Pharmacology
ISBN:
Category :
Languages : en
Pages : 460

Get Book Here

Book Description


A Plan for Action

A Plan for Action PDF Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 68

Get Book Here

Book Description


Drug Safety

Drug Safety PDF Author: Nigel S. B. Rawson
Publisher: FriesenPress
ISBN: 1460291018
Category : Medical
Languages : en
Pages : 212

Get Book Here

Book Description
With “Big Pharma” garnering an increasing number of negative headlines due to reports of adverse drug reactions and a surge in prescription drug addiction and overdose deaths, many people are increasingly skeptical about the safety of modern pharmaceutics and the moral integrity of the pharmaceutical industry. This book was written to provide a balanced perspective on drug safety risks. No therapeutic prescription drug is entirely risk-free. Before receiving marketing approval, new drugs go through arduous and expensive testing processes that can take up to a decade and cost over two billion dollars. While not perfect, the process is far from a “Wild West” environment where big pharmaceutical companies ride roughshod over government regulators. However, author and pharmacoepidemiologist Nigel Rawson argues, the antipathy that is common between governments, pharmaceutical industry and academic experts in Canada needs to change to an environment of collaboration and partnership to enhance our ability to respond in a timely fashion to future pharmaceutical crises. While directed mainly at students in the health sciences and pharmaceutical professionals, this book will be of interest to anyone, including lay people and policy makers, who would like to know more about the evolution of the prescription drug evaluation and risk assessment process. Although the book focuses primarily on Canada, it makes comparisons with the United States and Europe, and several of the author’s recommendations for how to improve the prescription drug evaluation process are applicable worldwide.